Smith JA, Kitt MM, Morice AH, et al. MK-7264, a P2X3 Receptor Antagonist, Reduces Cough Frequency in Patients with Refractory Chronic Cough: Results from a Randomized, Controlled, Phase 2b Clinical Trial. ATS 2017, A7608.
Verandering in gevoeligheid speeksel-PCR-test tijdens SARS-CoV-2-infectie
okt 2021 | Pneumonie, Virale infecties